83 related articles for article (PubMed ID: 15220534)
1. Analysis of checkpoint responses to histone deacetylase inhibitors.
Beamish H; Warrener R; Gabrielli BG
Methods Mol Biol; 2004; 281():245-59. PubMed ID: 15220534
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors induce mitotic slippage.
Stevens FE; Beamish H; Warrener R; Gabrielli B
Oncogene; 2008 Feb; 27(10):1345-54. PubMed ID: 17828304
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints.
Warrener R; Beamish H; Burgess A; Waterhouse NJ; Giles N; Fairlie D; Gabrielli B
FASEB J; 2003 Aug; 17(11):1550-2. PubMed ID: 12824307
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint.
Magnaghi-Jaulin L; Eot-Houllier G; Fulcrand G; Jaulin C
Cancer Res; 2007 Jul; 67(13):6360-7. PubMed ID: 17616695
[TBL] [Abstract][Full Text] [Related]
5. Analyzing cell cycle checkpoints after ionizing radiation.
Xu B; Kastan MB
Methods Mol Biol; 2004; 281():283-92. PubMed ID: 15220537
[TBL] [Abstract][Full Text] [Related]
6. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.
Noh EJ; Lim DS; Jeong G; Lee JS
Biochem Biophys Res Commun; 2009 Jan; 378(3):326-31. PubMed ID: 19038231
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors disrupt the mitotic spindle assembly checkpoint by targeting histone and nonhistone proteins.
Gabrielli B; Brown M
Adv Cancer Res; 2012; 116():1-37. PubMed ID: 23088867
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET.
Brest P; Gustafsson M; Mossberg AK; Gustafsson L; Duringer C; Hamiche A; Svanborg C
Cancer Res; 2007 Dec; 67(23):11327-34. PubMed ID: 18056459
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.
Qiu L; Burgess A; Fairlie DP; Leonard H; Parsons PG; Gabrielli BG
Mol Biol Cell; 2000 Jun; 11(6):2069-83. PubMed ID: 10848630
[TBL] [Abstract][Full Text] [Related]
10. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Ueda T; Takai N; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
[TBL] [Abstract][Full Text] [Related]
11. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
12. The EBNA-3 gene family proteins disrupt the G2/M checkpoint.
Krauer KG; Burgess A; Buck M; Flanagan J; Sculley TB; Gabrielli B
Oncogene; 2004 Feb; 23(7):1342-53. PubMed ID: 14716295
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins.
Ouwehand K; de Ruijter AJ; van Bree C; Caron HN; van Kuilenburg AB
FEBS Lett; 2005 Feb; 579(6):1523-8. PubMed ID: 15733867
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
15. DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.
Ree AH; Stokke T; Bratland A; Patzke S; Nome RV; Folkvord S; Meza-Zepeda LA; Flatmark K; Fodstad O; Andersson Y
Anticancer Res; 2006; 26(3A):1909-16. PubMed ID: 16827124
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.
Vogel C; Kienitz A; Hofmann I; Müller R; Bastians H
Oncogene; 2004 Sep; 23(41):6845-53. PubMed ID: 15286707
[TBL] [Abstract][Full Text] [Related]
17. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY
Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
[TBL] [Abstract][Full Text] [Related]
19. FACS-based detection of phosphorylated histone H3 for the quantitation of mitotic cells.
Taylor WR
Methods Mol Biol; 2004; 281():293-9. PubMed ID: 15220538
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
